Literature DB >> 2826581

Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.

P J Knudsen1, C A Dinarello, T B Strom.   

Abstract

We investigated effects of corticosteroids on interleukin 1 (IL-1) production in monocyte-like tumor cell line, U937. Release of IL-1 activity by bacterial toxin-stimulated cells was completely blocked by 10 nM dexamethasone (Dex). We examined the question whether corticosteroids suppress IL-1 production by blocking transcription of IL-1 mRNA, or by blocking IL-1 synthesis at a post-transcriptional step. Northern blot hybridization analysis indicated that Dex, 10 nM, completely blocked accumulation of IL-1 beta-encoding mRNA in U937 cells. Dex-mediated inhibition of IL-1 release appeared to be glucocorticoid receptor-mediated and was abrogated by progesterone. In addition, Dex at high concentrations could inhibit post-transcriptional synthesis of IL-1 by prestimulated U937 cells. Although Dex, 500 nM, did not change IL-1 mRNA levels in prestimulated cells, it completely blocked IL-1 release and induced a transient increase in cellular cyclic adenosine 3',5'-monophosphate (cAMP) levels. Dex-mediated inhibition of IL-1 release in prestimulated cells is likely to occur via increased levels of cAMP, which have been shown to block post-transcriptional IL-1 synthesis. Our results indicate that glucocorticoids suppress IL-1 synthesis by two distinct mechanisms, blocking transcription of IL-1 mRNA during monocyte activation, and blocking post-transcriptional IL-1 synthesis via cAMP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2826581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

2.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

3.  Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome.

Authors:  John M Busillo; Kathleen M Azzam; John A Cidlowski
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

Review 4.  Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.

Authors:  B Kirkham
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

5.  A novel mechanism of glucocorticoid-induced immune suppression: the inhibiton of T cell-mediated terminal maturation of a murine dendritic cell line.

Authors:  T Kitajima; K Ariizumi; P R Bergstresser; A Takashima
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

Review 6.  Pharmacological implications for neuroreceptor imaging.

Authors:  N P Verhoeff
Journal:  Eur J Nucl Med       Date:  1991

7.  Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.

Authors:  Z Zídek
Journal:  Agents Actions       Date:  1994-10

8.  The effect of adrenalectomy on interleukin-1 release in vitro and in vivo.

Authors:  M Perretti; C Becherucci; G Scapigliati; L Parente
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

9.  Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells.

Authors:  D W Kimberlin; S A Willis; G H McCracken; P D Nisen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

10.  Lipopolysaccharide-induced lethality and cytokine production in aged mice.

Authors:  K Tateda; T Matsumoto; S Miyazaki; K Yamaguchi
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.